Discovery of novel and orally active inhibitors of lck kinase.

被引:0
|
作者
Goldberg, D [1 ]
Butz, T [1 ]
Cardozo, M [1 ]
Eckner, R [1 ]
Hammach, A [1 ]
Huang, J [1 ]
Jakes, S [1 ]
Kapadia, S [1 ]
Lukas, S [1 ]
Morwick, T [1 ]
Moss, N [1 ]
Panzenbeck, M [1 ]
Patel, U [1 ]
Peet, G [1 ]
Peterson, J [1 ]
Prokopowicz, A [1 ]
Snow, RJ [1 ]
Takahashi, H [1 ]
Tan, J [1 ]
Tschantz, M [1 ]
Wang, XJ [1 ]
Xiang, P [1 ]
Zinter, R [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
24-MEDI
引用
收藏
页码:U643 / U643
页数:1
相关论文
共 50 条
  • [21] APPROACH TO THE DISCOVERY OF NOVEL, SELECTIVE INHIBITORS OF P56(LCK) TYROSINE KINASE - IDENTIFICATION OF NON-HYDROXYLATED CHROMONES AS P56(LCK) INHIBITORS
    MILLER, D
    WANG, S
    REID, J
    XIE, W
    GAUVIN, B
    KELLEY, M
    SARUP, J
    SAWUTZ, DG
    MISKI, M
    DOLLE, RE
    FALTYNEK, CR
    DRUG DEVELOPMENT RESEARCH, 1995, 34 (04) : 344 - 352
  • [22] Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: Synthesis, SAR, and in vivo antiinflammatory activity
    Martin, Matthew W.
    Newcomb, John
    Nunes, Joseph J.
    McGowan, David C.
    Armistead, David M.
    Boucher, Christina
    Buchanan, John L.
    Buckner, William
    Chai, Lilly
    Elbaum, Daniel
    Epstein, Linda F.
    Faust, Theodore
    Flynn, Shaun
    Gallant, Paul
    Gore, Anu
    Gu, Yan
    Hsieh, Faye
    Huang, Xin
    Lee, Josie H.
    Metz, Daniela
    Middleton, Scot
    Mohn, Deanna
    Morgenstern, Kurt
    Morrison, Michael J.
    Novak, Perry M.
    Oliveira-dos-Santos, Antonio
    Powers, David
    Rose, Paul
    Schneider, Stephen
    Sell, Stephanie
    Tudor, Yanyan
    Turci, Susan M.
    Welcher, Andrew A.
    White, Ryan D.
    Zack, Debra
    Zhao, Huilin
    Zhu, Li
    Zhu, Xiaotian
    Ghiron, Chiara
    Amouzegh, Patricia
    Ermann, Monika
    Jenkins, James
    Johnston, David
    Napier, Spencer
    Power, Eoin
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (16) : 4981 - 4991
  • [23] Discovery and development of orally active P38 kinase inhibitors as anti-TNF agents
    Devraj, RV
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U161 - U161
  • [24] Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors
    Pinard, Emmanuel
    Alberati, Daniela
    Bender, Markus
    Borroni, Edilio
    Brom, Virginie
    Burner, Serge
    Fischer, Holger
    Hainzl, Dominik
    Halm, Remy
    Hauser, Nicole
    Jolidon, Synese
    Lengyel, Judith
    Marty, Hans-Peter
    Meyer, Thierry
    Moreau, Jean-Luc
    Mory, Roland
    Narquizian, Robert
    Norcross, Roger D.
    Schmid, Philipp
    Wermuth, Roger
    Zimmerli, Daniel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6960 - 6965
  • [25] Discovery of potent and orally active farnesyltransferase (FT) inhibitors.
    Tong, YS
    Wang, L
    Hasvold, L
    Leonard, N
    Li, TM
    Li, Q
    Wang, WB
    Cohen, J
    Gu, WZ
    Zhang, HY
    Bauch, J
    Marsh, K
    Rosenberg, SH
    Lin, NH
    Sham, HL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U29 - U29
  • [26] The active site of arginine kinase.
    Binz, S
    Speckhard, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U422 - U422
  • [27] Optimization of 2-phenylaminoimidazo[4,5-h]isoquinolin-9-ones:: Orally active inhibitors of lck kinase
    Goldberg, DR
    Butz, T
    Cardozo, MG
    Eckner, RJ
    Hammach, A
    Huang, J
    Jakes, S
    Kapadia, S
    Kashem, M
    Lukas, S
    Morwick, TM
    Panzenbeck, M
    Patel, U
    Pav, S
    Peet, GW
    Peterson, JD
    Prokopowicz, AS
    Snow, RJ
    Sellati, R
    Takahashi, H
    Tan, J
    Tschantz, MA
    Wang, XJ
    Wang, Y
    Wolak, J
    Xiong, P
    Moss, N
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (08) : 1337 - 1349
  • [28] Synthesis and biological evaluation of a series of novel and potent inhibitors of KDR kinase.
    Tucker, TJ
    Ciecko, PA
    Coll, KE
    Hartman, GD
    Lumma, WC
    Merkle, K
    McFall, RC
    McGaughey, GB
    Rickert, K
    Shipman, JM
    Singh, R
    Sisko, JT
    Smith, AM
    Thomas, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U44 - U44
  • [29] Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors
    Luo, Guanglin
    Chen, Ling
    Burton, Catherine R.
    Xiao, Hong
    Sivaprakasam, Prasanna
    Krause, Carol M.
    Cao, Yang
    Liu, Nengyin
    Lippy, Jonathan
    Clarke, Wendy J.
    Snow, Kimberly
    Raybon, Joseph
    Arora, Vinod
    Pokross, Matt
    Kish, Kevin
    Lewis, Hal A.
    Langley, David R.
    Macor, John E.
    Dubowchik, Gene M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (03) : 1041 - 1051
  • [30] Structure-based drug design:: the discovery of novel nonpeptide orally active inhibitors of human renin
    Rahuel, J
    Rasetti, V
    Maibaum, J
    Rüeger, H
    Göschke, R
    Cohen, NC
    Stutz, S
    Cumin, F
    Fuhrer, W
    Wood, JM
    Grütter, MG
    CHEMISTRY & BIOLOGY, 2000, 7 (07): : 493 - 504